Thoracic Service Line

Thoracic

PATHOLOGY

Pneumothorax & Pleural effusion triage

Vendor

Nanoxai

APP HEALTHPNX+ Device & HEALTHCXR Device

DESCRIPTION

Nanox.AI Chest Solution automatically identifies suspected findings suggestive of pneumothorax and pleural effusion on chest x-rays. The software notifies PACS/ workstation of the presence of the critical findings.1,2

MODALITY
X-Ray


HealthPNX+ Device and HealthCXR Device have CE marking (CE2195) and risk class IIa.

PATHOLOGY

Lung nodule detection

Vendor

Riverain

APP ClearRead CT

DESCRIPTION

ClearRead CT allows suppression of vascular, bronchial and fissural structures enabling an improved visibility of lung nodules. It also enables the detection, quantification and characterization of solid, part solid and ground glass pulmonary nodules on CT chest scans.3

MODALITY
CT


ClearRead CT has CE marking (CE2862) and risk class IIa.

PATHOLOGY

COPD & ILD

Vendor

Nanoxai

APP VIDA Insights

DESCRIPTION

VIDA Insights provides quantitative chest CT analysis used to profile and manage patients with/or at-risk of lung disease. It provides a flag of lung density abnormalities that may be indicative of emphysema (COPD) or interstitial lung abnormalities (ILAs).4

MODALITY
CT


VIDA Insights has CE marking (CE0413) and risk class IIa.

PATHOLOGY

Covid-19

Vendor

Nanoxai

APP icolung ct

DESCRIPTION

icolung ct supports automatic labeling, visualization and volumetric quantification of segmentable lung structures from non-contrast enhanced chest CT. It also measures percentage of abnormality in each lobe and in total lungs.5

MODALITY
CT


Icolung ct has CE marking (CE1639) and risk class Im.

Not all offerings are available in all market. For availability specific to your country please contact your local Bayer representative.

Contraindications: HealthPNX+ device and HealthCXR device should not be used to analyze scans of patients under 18 years old, scans which are not AP or PA chest x-ray, scans with severe missing image artifacts, scans missing parts of the chest cavity or scans that are unnaturally monochrome in nature (too black or too white). Non-standard scans may skew analysis results, and if such scans are sent to the HealthPNX+device or HealthCXR device, physicians should disregard results from the scans. No other contraindications are described.

  1. Instructions for Use HealthPNX+ V2.0: Pneumothorax Triage Device, software version 2.0
  2. Instructions for Use HealthCXR Triage Device, software version 1.0
  3. Instructions for Use ClearRead CT, software version 3.6.0 - 5.5.0
  4. Instructions for Use icolung ct, software version 0.7.2
Alt tag

© 2023 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

PP-CALA-ALL-0464-1 November 2023

 

Bayer Logo